Paydirt
MH
Insider

Michael Thomas Henderson

Director

Michael Thomas Henderson (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $10.6M of APGE (80,000 sh × $132.54, as filed), executed Jun 22.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$36.0M
shares × price, as filed
Last traded
Jul 8
Filed Jul 10

Median ADV $371.2M across their filed names

Open performance
Volume by month
$14.1M$7.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $2.2MNov 2024 · sells $828KDec 2024 · sells $620KJan 2025 · sells $733KFeb 2025 · sells $609KMar 2025 · sells $220KNov 2025 · sells $1.3MDec 2025 · sells $4.5MJan 2026 · sells $1.6MFeb 2026 · sells $1.2MMar 2026 · sells $1.5MApr 2026 · sells $1.6MMay 2026 · sells $7.6MJun 2026 · sells $14.1MJul 2026 · sells $2.7M
Buys $0 Sells $41.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 13 filings

Sector per market data · by filing · past 12 months

Most traded names
APGE Apogee Therapeutics, Inc. APGE · 0 buys · 17 sells 17 filings SYRE Spyre Therapeutics, Inc. SYRE · 0 buys · 2 sells 2 filings
Recent filings
APGESALE Apogee Therapeutics, Inc. View filing → $2.7M
20,000 sh × $133.63
Exec Jul 8
Filed Jul 10 · 8:00 PM ET
SYRESALE Spyre Therapeutics, Inc. View filing → $2.0M
20,000 sh × $100.00
Exec Jun 22
Filed Jun 23 · 5:30 PM ET
APGESALE Apogee Therapeutics, Inc. View filing → $10.6M
80,000 sh × $132.54
Exec Jun 22
Filed Jun 24 · 5:30 PM ET
APGESALE Apogee Therapeutics, Inc. View filing → $1.5M
18,306 sh across 4 lots
Exec Jun 10
Filed Jun 12 · 5:30 PM ET
APGESALE Apogee Therapeutics, Inc. View filing → $1.6M
20,000 sh across 2 lots
Exec May 13
Filed May 15 · 5:30 PM ET
SYRESALE Spyre Therapeutics, Inc. View filing → $6.0M
80,000 sh across 4 lots
Exec May 8
Filed May 8 · 5:30 PM ET
APGESALE Apogee Therapeutics, Inc. View filing → $1.6M
19,800 sh across 2 lots
Exec Apr 8
Filed Apr 10 · 5:30 PM ET
APGESALE Apogee Therapeutics, Inc. View filing → $1.5M
20,000 sh across 3 lots
Exec Mar 11
Filed Mar 13 · 5:30 PM ET
More filings →